Studiegids

nl en

Bio-Pharmaceutical Sciences: BioTherapeutics

Master

BioTherapeutics is a specialisation of the Master’s programme Bio-Pharmaceutical Sciences of Leiden University. It offers research-orientated education on the areas of specific drug delivery techniques, and the development of new therapeutic approaches to treat immune-based disorders, such as atherosclerosis, metabolic disorders and inflammatory skin diseases. Research Project 1 will be conducted at the division BioTherapeutics of the LACDR on one of the research themes described below.

One mission of the division is to provide new strategies for the delivery of biologically active compounds at the right dose, at the right time and at the right place. Research activities are organized in two major, interrelated research lines: “Skin Research” and ”Biologics Research”. New research goes beyond conventional immunization, such as designing non-invasive delivery routes and microneedles.

The division also focusses on the development of experimental therapeutic approaches to treat cardiovascular disease and atherosclerosis. To study the complex interaction of drugs in different organic systems, research is performed at the gene, immune cell and lipid level in various in vitro and in vivo models; one of the strengths of the Division of BioTherapeutics. Interventions developed so far range from bone marrow transplantation to experimental therapies using antibody-based interventions, therapeutic vaccines, and gene therapeutic approaches.

  • First and Second Year
  • Meer info
Vak EC Semester 1 Semester 2

Mandatory courses:

Advanced Academic Skills and Career Orientation 3
Introduction Course Bio-Pharmaceutical Sciences 4
Literature Study LACDR 7

Research Project 1 at the division of BioTherapeutics

Research Project 1 - Practical Work 44
Research Project 1 - Thesis 5
Research Project 1 - Oral Presentation 2

The MSc programme of Bio-Pharmaceutical Sciences offers the following Lecture Series in the academic year 2018–2019 (one of these is mandatory):

Regulation of Drug Safety 4
Atherosclerosis 4
Capillary Electrophoresis-Mass Spectrometry for Metabolomics 4
Biophysics and Bioengineering for Pharmaceutical Sciences 4
Bioanalytical Mass Spectrometry 4
Signal Transduction and Hallmarks of Cancer 4
Quantitative Pharmacology 4
Model organisms in cancer drug discovery and development 4
Drug Delivery 4
Cell adhesion signaling in health and disease 4
Blood-Brain Barrier: Drug Transport to the Brain 4

Optional courses in the academic year 2018–2019 (list is not restrictive):

IP Law in Science 5
Science Methodology (SCM) 4
Science and the public: contemporary and historical perspectives 6